Bank Of New York Mellon Corp Bluebird Bio, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$3.14 - $8.22 $1.25 Million - $3.28 Million	398,580 New	398,580 $1.27 Billion
Q4 2022 Feb 14, 2023	BUY	$5.77 - $8.49 $2.01 Million - $2.95 Million	347,819 New	347,819 $2.41 Million
Q3 2022 Nov 14, 2022	BUY	$3.75 - $7.39 $95,925 - $189,036	25,580 Added 8.59%	323,492 $2.05 Million
Q2 2022 Aug 15, 2022	BUY	$2.94 - $5.23 $73,526 - $130,797	25,009 Added 9.16%	297,912 $1.23 Million
Q1 2022 May 11, 2022	BUY	$4.07 - $10.6 $12,079 - $31,460	2,968 Added 1.1%	272,903 $1.32 Million
Q4 2021 Feb 11, 2022	SELL	$8.96 - $16.31 $569,148 - $1.04 Million	-63,521 Reduced 19.05%	269,935 $2.7 Million
Q3 2021 Nov 12, 2021	BUY	$11.24 - $21.0 $207,940 - $388,500	18,500 Added 5.87%	333,456 $6.37 Million
Q2 2021 Aug 11, 2021	BUY	$18.04 - $22.09 $1.65 Million - $2.02 Million	91,503 Added 40.95%	314,956 $6.52 Million
Q1 2021 May 13, 2021	SELL	$16.59 - $33.89 $318,561 - $650,755	-19,202 Reduced 7.91%	223,453 $4.36 Million
Q4 2020 Feb 09, 2021	SELL	$27.5 - $37.92 $122,980 - $169,578	-4,472 Reduced 1.81%	242,655 $6.8 Million
Q3 2020 Nov 12, 2020	SELL	$34.44 - $43.75 $141,513 - $179,768	-4,109 Reduced 1.64%	247,127 $8.63 Million
Q2 2020 Aug 12, 2020	BUY	$27.12 - $45.97 $1.39 Million - $2.36 Million	51,260 Added 25.63%	251,236 $9.93 Million
Q1 2020 May 06, 2020	SELL	$26.16 - $63.5 $181,419 - $440,372	-6,935 Reduced 3.35%	199,976 $5.95 Million
Q4 2019 Feb 14, 2020	SELL	$46.96 - $61.67 $172,014 - $225,897	-3,663 Reduced 1.74%	206,911 $11.8 Million
Q3 2019 Nov 07, 2019	BUY	$59.47 - $93.1 $228,721 - $358,062	3,846 Added 1.86%	210,574 $12.5 Million
Q2 2019 Aug 12, 2019	SELL	$75.84 - $105.21 $585,636 - $812,431	-7,722 Reduced 3.6%	206,728 $26.3 Million
Q1 2019 May 14, 2019	SELL	$64.44 - $104.11 $709,162 - $1.15 Million	-11,005 Reduced 4.88%	214,450 $33.7 Million
Q4 2018 Feb 11, 2019	SELL	$59.1 - $93.26 $21.1 Million - $33.2 Million	-356,240 Reduced 61.24%	225,455 $22.4 Million
Q3 2018 Nov 09, 2018	BUY	$88.86 - $117.49 $23.9 Million - $31.6 Million	269,074 Added 86.07%	581,695 $0
Q2 2018 Aug 06, 2018	SELL	$99.64 - $127.59 $4.58 Million - $5.87 Million	-45,998 Reduced 12.83%	312,621 $49.1 Million
Q1 2018 May 15, 2018	BUY	$105.8 - $150.94 $3.4 Million - $4.86 Million	32,173 Added 9.86%	358,619 $61.2 Million
Q4 2017 Feb 09, 2018	BUY	$81.25 - $130.7 $26.5 Million - $42.7 Million	326,446	326,446 $58.1 Million

Others Institutions Holding BLUE

# of Institutions

146

Shares Held

63.3M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$129 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$87.5 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$39.1 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$39 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$32.1 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $644M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account